|
|
CEREP - Comparative Business Analysis Snapshot
Business Description
CEREP. The Group's principal activity is to assist the pharmaceutical and biotechnology companies in their search for effective and safe drugs. The Group provides services under Clinical Services. The Group also provides services in the field of Collaboration & Drug Discovery which range from molecular modeling and custom synthesis of libraries to lead optimization. The Group's products and services are available to the customers through flexible business models, from pure "fee for service" to integrated collaborations and partnerships. The Group also provides pharmacology and ADMET data to pharma and biotech companies worldwide. Under Clinical Services, the Group offers clinical trials management and monitoring, data management, biostatistical analysis, clinical pharmacology and other drug development consulting services. The Group operates in Europe, North America and Asia.
Competitor Analysis
This analysis compares CEREP with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
|
|
|
|
